eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

How to?

Review: Reglan and Ranitidine

This review analyzes the effectiveness and drug interactions between Reglan and Ranitidine. It is created by eHealthMe based on reports of 9 people who take the same drugs from FDA and social media, and is updated regularly.

Stay connected: join a mobile support group for people who take Reglan and Ranitidine >>>

What are the drugs

Reglan (latest outcomes from 19,974 users) has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis.

Ranitidine (latest outcomes from 975 users) has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease.

On Jul, 16, 2014: 9 people who take Reglan, Ranitidine are studied

Reglan, Ranitidine outcomes

Drug combinations in study:
- Reglan (metoclopramide hydrochloride)
- Ranitidine (ranitidine)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Reglan is effective100.00%
(1 of 1 people)
0.00%
(0 of 1 people)
n/an/an/an/an/an/a
Ranitidine is effective100.00%
(1 of 1 people)
0.00%
(0 of 1 people)
n/an/an/an/an/an/a

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Embolismn/an/an/an/an/an/aSkin Induration
Pulmonary Fibrosis
Nephrogenic Systemic Fibrosis
Skin Tightness
Subcutaneous Nodule
Toxic Epidermal Necrolysis
Xerosis
Myocardial Fibrosis
Pain In Extremity
Metaplasia

Drug effectiveness by gender :

FemaleMale
Reglan is effective50.00%
(1 of 2 people)
n/a
Ranitidine is effective50.00%
(1 of 2 people)
n/a

Most common drug interactions by gender * :

FemaleMale
Febrile NeutropeniaSkin Induration
Pulmonary Fibrosis
Nephrogenic Systemic Fibrosis
Skin Tightness
Subcutaneous Nodule
Toxic Epidermal Necrolysis
Xerosis
Myocardial Fibrosis
Pain In Extremity
Fibrosis

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Reglan is effectiven/an/an/an/a0.00%
(0 of 1 people)
100.00%
(1 of 1 people)
n/an/a
Ranitidine is effectiven/an/an/an/a0.00%
(0 of 1 people)
100.00%
(1 of 1 people)
n/an/a

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
n/an/aSkin Indurationn/an/an/aFebrile NeutropeniaToxic Epidermal Necrolysis
Pulmonary FibrosisSkin Disorder
Skin TightnessRash Erythematous
Subcutaneous NoduleGrand Mal Convulsion
XerosisBlood Glucose Decreased
Nephrogenic Systemic Fibrosis
Pain In Extremity
Metaplasia
Fibrosis
Discomfort

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Get connected! Join a mobile support group:
- group for people who take Reglan and Ranitidine
- group for people who take Ranitidine
- group for people who take Reglan

Can you answer these questions (what is this?):

More questions for: Ranitidine, Reglan

More reviews for: Ranitidine, Reglan

Complete drug side effects:

On eHealthMe, Reglan (metoclopramide hydrochloride) is often used to treat gastroparesis. Ranitidine (ranitidine) is often used to treat gastroesophageal reflux disease. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

38 million health professionals and patients have studied on eHealthMe. Recent studies:

- Vitamin B6 for a 14-year old boy who has Autism (20 minutes ago)

- Trazodone Hydrochloride, Suboxone, Levothyroxine Sodi ... (35 minutes ago)

- Ativan for a 39-year old woman who has Sleep Disorder (37 minutes ago)

Related studies

- Ranitidine side effects
- Reglan side effects

 

 

Recent user comments

- "Low dosage and first one pill. Toke it at morning, na ... " (43 minutes ago)

- "Take Rhus Tox daily to diminish sensitivity to/severi ... " (3 hours ago)

- "Also utilizing testosterone pellet therapy for low te ... " (4 hours ago)

 

Recent mobile support groups

- Histamine Intolerance

- Inhame-bravo and Chinese Goldenseal

- Lamivudine and Acyclovir

- Lexapro and Bradycardia Neonatal

- Indian Chocolate and Parsidol

 

Popular searches

- Amiloride Hydrochloride And Hydrochlorothiazide
- Intracranial Injury
- Prozac
- Weight Increased
- Loratadine

   

Drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Side effects: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Symptoms: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.